Literature DB >> 1516258

Prevalence of anti-Fab antibodies in patients with autoimmune and infectious diseases.

J Hassan1, C Feighery, B Bresnihan, A Whelan.   

Abstract

Sensitive ELISA were devised to examine the specificity of circulating IgM and IgA autoantibodies for whole human IgG, Fc and Fab fragments of human IgG. Sera from patients with autoimmune and infectious conditions such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), tuberculosis (TB), infectious mononucleosis (IM) and cystic fibrosis (CF) were studied. Results of the ELISA assays using whole human IgG as antigen revealed that a proportion of patients in each of the groups studied had circulating IgM and IgA rheumatoid factors (RF). Fifteen normal individuals studied were negative. In the latex positive RA group, IgM RF and IgA RF had primarily anti-Fc reactivity (100% and 93% respectively), although 3/15 patients also showed IgM anti-Fab reactivity and one patient had high IgA anti-Fab activity. Patients with SLE and TB who had detectable RF levels also revealed predominantly anti-Fc specificity. In contrast, examination of 25 patients with IM showed positivity for IgM RF activity in 8% of patients using whole IgG as antigen, 24% positivity using purified Fc fragments as antigen and 45% positivity when plates were coated with Fab fragments. Similarly, a large number of CF patients (54%) also showed predominantly IgM anti-Fab activity. Of interest, 69% of the CF patients who were all studied at the time of bacterial infection had detectable IgA RF levels, with 46% of these patients showing both IgA anti-Fc and anti-Fab activity. These findings suggest that autoantibody specificities in autoimmune and infectious diseases are different.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516258      PMCID: PMC1554491          DOI: 10.1111/j.1365-2249.1992.tb06974.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  CLINICAL, PATHOLOGIC, AND SEROLOGIC STUDIES IN SJOEGREN'S SYNDROME; COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.

Authors:  J J BUNIM; W W BUCHANAN; P T WERTLAKE; L SOKOLOFF; K J BLOCH; J S BECK; F P ALEPA
Journal:  Ann Intern Med       Date:  1964-09       Impact factor: 25.391

2.  Anti-gamma-globulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies.

Authors:  C K OSTERLAND; M HARBOE; H G KUNKEL
Journal:  Vox Sang       Date:  1963 Mar-Apr       Impact factor: 2.144

3.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

4.  Increased CD5+ B cells in infectious mononucleosis.

Authors:  J Hassan; C Feighery; B Bresnihan; A Whelan
Journal:  Br J Haematol       Date:  1990-03       Impact factor: 6.998

5.  The relationship between circulating CD5+ B lymphocytes and in vitro autoantibody synthesis in normal individuals.

Authors:  H E Jasin
Journal:  Cell Immunol       Date:  1991-08       Impact factor: 4.868

6.  Radioimmunoassay of IgG and IgM rheumatoid factors reacting with human IgG.

Authors:  D A Carson; S Lawrance; M A Catalano; J H Vaughan; G Abraham
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

7.  Systemic lupus erythematosus. A prospective analysis.

Authors:  R Grigor; J Edmonds; R Lewkonia; B Bresnihan; G R Hughes
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

8.  Continuous production of anti-host IgG antibodies contained in circulating IgG-anti-IgG complexes.

Authors:  S A Grace; C J Elson
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

9.  IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis.

Authors:  M Gioud-Paquet; M Auvinet; T Raffin; P Girard; M Bouvier; E Lejeune; J C Monier
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

10.  IgG rheumatoid factor in subacute bacterial endocarditis: relationship to IgM rheumatoid factor and circulating immune complexes.

Authors:  D A Carson; A S Bayer; R A Eisenberg; S Lawrance; A Theofilopoulos
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

View more
  2 in total

Review 1.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

2.  IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells.

Authors:  M Callaghan; A Whelan; C Feighery; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.